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Objective  To determine the major risk factors and abnormal videofl  uoroscopic swallowing study (VFSS) fi  ndings 
associated with aspiration in patients with head and neck cancer (HNC). 
Method  Risk factors associated with aspiration were investigated retrospectively in 241 patients with HNC using 
medical records and pre-recorded VFSS. Age, gender, lesion location and stage, treatment factors, and swallowing 
stage abnormalities were included. 
Results  Aspiration occurred in 50.2% of patients. A univariate analysis revealed that advanced age, increased 
duration from disease onset to VFSS, higher tumor stage, increased lymph node stage, increased American Joint 
Committee on Cancer (AJCC) stage, operation history, chemotherapy history, and radiotherapy history were 
significantly associated with aspiration (p<0.05). Among them, advanced age, increase AJCC stage, operation 
history, and chemotherapy history were significantly associated with aspiration in the multivariate analysis 
(p<0.05). Delayed swallowing reflex and reduced elevation of the larynx were significantly associated with 
aspiration in the multivariate analysis (p<0.05). 
Conclusion  The major risk factors associated with aspiration in patients with HNC were advanced age, higher 
AJCC stage, operation history, and chemotherapy history. A VFSS to evaluate aspiration is needed in patients 
with NHC who have these risk factors. Delayed swallowing refl  ex and reduced elevation of the larynx were major 
abnormal fi  ndings associated with aspiration. Dysphagia rehabilitation should focus on these results. 
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INTRODUCTION
  Head and neck cancer (HNC) includes tumors extending 
into the oral cavity, the pharynx, and the larynx. It arises 
in anatomical regions related to the swallowing function, 
but the incidence rate of aspiration varies from 36-94% 
in patients with HNC.
1-6 Additionally, the incidence rate 
of a silent aspiration, caused by the decline in cough 
reflex, is 22-67%.
7-9 Nevertheless, many cases occur in 
which an aspiration passes unnoticed in clinical practice. 
Aspiration may not only occur due to cancer but also due 
to surgery, radiotherapy, or chemotherapy.
10 Aspiration 
may cause pneumonia and malnutrition in patients with 
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HNC and, thus, may affect prognosis,
6,11 particularly in 
patients whose immune system is impaired by cancer 
treatment. Even mild aspiration may lead to sepsis or 
respiratory failure.
1
  Accordingly, it is important to screen patients with HNC, 
who have a high risk for aspiration, to conduct systematic 
examinations of the aspiration and swallowing processes, 
and to undergo dysphagia rehabilitation. Some studies 
have attempted to identify risk factors for aspiration in 
patients with HNC,
3,12-14 whereas very few systematic 
and large scale studies in patients with HNC have been 
conducted in Korea. If high-risk patients are screened to 
identify risk factors for aspiration, aspiration can be more 
carefully monitored in clinical practice, which would 
positively influence the prognosis. Additionally, the 
pathogenetic mechanism of aspiration can be explained 
if the factors responsible for aspiration can be identifi  ed 
on a videofluoroscopic swallowing study (VFSS), which 
will be helpful for dysphagia rehabilitation.
  This study identified risk factors for aspiration in 
patients with HNC and conducted a VFSS for the 
swallowing process. We enrolled 242 patients who 
were diagnosed with HNC and who underwent VFSS at 
Yonsei University Medical Center. Medical records were 
retrospectively analyzed for demographic information, 
HNC characteristics, and a history of cancer treatment.
MATERIALS AND METHODS
Subjects
  This study was conducted on 221 of 242 patients who 
were diagnosed with HNC and who underwent VFSS 
between April 2007 and December 2010 at Yonsei Uni-
versity Medical Center. Twenty-one patients were ex-
cluded due to inadequate imaging studies, histological 
fi  ndings, tumor locations, and tumor stages (11), or if the 
medical treatment history could not be traced (3) and 
where strokes, head and neck trauma, and degenerative 
neurologic diseases occurred in the past (7). The mean 
age of the patients was 57.7 years. There were 173 men 
(78.3%) and 48 (21.7%) women. They had VFSS an 
average of 8.88 months after being diagnosed with HNC. 
Dysphagia occurred in 155 (70.1%) patients. Tumors 
were located in the oropharynx (74, 33.5%), larynx (15, 
6.8%), hypopharynx (18, 8.1%), oral cavity (98, 44.3%), 
nasopharynx (10, 4.5%), and salivary glands (6, 2.7%). 
Table 1. General Subject Characteristics 
Characteristics Value (n, %)
 Sex
Male 173 (78.3)
Female   48 (21.7)
Age (year)
Mean 57.7±13.1
Range 21-79
Time interval from onset (months) 8.8±15.6
<3 108 (48.9)
3-6   23 (10.4)
6-12   33 (14.9)
≥12   57 (25.8)
Lesion
Oropharynx   74 (33.5)
Larynx 15 (6.8)
Hypopharynx 18 (8.1)
Oral cavity   98 (44.3)
Nasopharynx 10 (4.5)
Salivary gland   6 (2.7)
Tumor stage
T1   70 (31.6)
T2   78 (35.2)
T3   31 (14.0)
T4   42 (19.0)
Nodal stage
N0   80 (36.2)
N1   39 (17.6)
N2 102 (46.2)
AJCC stage
I   42 (19.0)
II   53 (24.0)
III   78 (35.3)
IVa   48 (21.7)
Treatment
None   96 (43.4)
Op   80 (36.2)
Op+CTx or RTx   8 (3.7) 
Op+CTx+RTx   22 (10.0)
Others 15 (6.7)
Swallowing performance scale
1   66 (29.9)
2   82 (37.1)
3   30 (13.5)
4 18 (8.1)
5   6 (2.7)
6   4 (1.8)
7 15 (6.7)
Op: Operation, CTx: Chemotherapy, RTx: RadiotherapyRick Factors of Aspiration in Head and Neck Cancer
783 www.e-arm.org
Regarding classifi  cation of the American Joint Committee 
on Cancer (AJCC) stage, 42 (19.0%), 53 (24.0%), 78 
(35.3%), and 48 (21.7%) were classifi  ed as stage I, stage II, 
stage III, and stage IVa, respectively. Ninety-six (43.4%) 
patients did not start treatment, 80 (36.2%) underwent 
only an operation, eight (3.7%) underwent both an 
operation and chemotherapy or radiotherapy, and 22 
(10.0%) underwent an operation and chemoradiotherapy.
  In relation to Karnell and MacCracken’s swallowing 
performance scale (SPS),
15 66 (29.9%), 82 (37.1%), 30 
(13.5%), 18 (8.1%), 6 (2.7%), 4 (1.8%) and 15 (6.7%) were 
classifi  ed as grades 1-7 in the order named (Table 1).
Methods
  Data collected from medical records and the VFSS were 
analyzed retrospectively. Patient information such as age 
and gender, tumor locations, tumor sizes, lymph node 
stages, AJCC stages,
16 SPS,
15 and a history of operations, 
chemotherapy, or radiotherapy were analyzed at the 
time of VFSS. To perform VFSS, 5 or 15 cc of 12% or 6% 
semisolid or liquid containing gastrograffi   n were used in 
each patient. VFSS was performed on a lateral view using 
radiologic fluoroscopy (Winscope, Toshiba, Japan), and 
images were recorded in real time. Abnormalities in the 
swallowing process were evaluated in detail using the 
real-time recorded images. Patients with aspiration were 
sorted out, and aspiration was defi  ned as bolus passing 
through the vocal cords once.
17
  Age, gender, duration from onset to examination, tumor 
location, tumor size, lymph node stage, AJCC stage, and 
cancer treatment modalities were regarded as risk factors 
for aspiration. Patients <65 years were distinguished 
from those aged ≥65 years.
18 The duration from onset 
to examination was defined from the day when the 
HNC diagnosis was given until the day when VFSS was 
performed. Th   e duration from onset to examination was 
classifi  ed into four periods based on Petterson et al.
19 (<3 
months, 3 months, longer than 3 months but less than 6 
months, greater than 6 months but less than 12 months, 
and ≥12 months). Patients with HNC that extended 
into the larynx or pharynx (laryngeal, oropharyngeal or 
hypopharyngeal cancers) were distinguished from those 
with HNC extending into the oral cavity (oropharyngeal, 
oral cavity, or salivary gland cancers).
20 T1 and T2 tumors 
were distinguished from T3 and T4 tumors. N0 stage 
lymph nodes were distinguished from N1 and N2 nodes. 
AJCC stages I and II were distinguished from stages III 
and IV.
  Th   e chi-square test was performed to confi  rm whether 
the foregoing factors influenced aspiration. Forward 
step  wise multivariate logistic regression analyses were 
conducted on statistically significant factors, in  depen-
dent risk factors were evaluated, and odd ratios were 
calculated. The main factor was identified in the same 
way as the foregoing factors for aspiration-related 
abnormal findings detected on the VFSS. All statistical 
data were analyzed with SPSS version 17.0 for Windows 
(SPSS Inc., Chicago, USA). A p-value<0.05 was considered 
signifi  cant.
RESULTS
VFSS results 
  Aspiration was detected in 111 (50.2%) of 221 patients. 
Oral phase dysphagia and pharyngeal phase dysphagia 
were detected in 40 (18.1%) and 154 (69.7%) respectively, 
one (0.4%) of whom showed dysphagia only at the oral 
phase. Dysphagia occurred only at the pharyngeal phase 
in 115 (52.0%) patients. Dysphagia occurred not only 
at the oral phase but also at the pharyngeal phase in 39 
(17.6%). Th   us, pharyngeal dysphagia comprised a higher 
proportion than that of oral dysphagia. Inadequate 
ton  gue movement was detected in 25 (11.3%) patients 
with oral phase dysphagia and comprised the highest 
proportion. Patients with a vallecular remnant comprised 
Table 2. Videofl  uoroscopic Swallowing Study Findings in 
Patients with Head and Neck Cancer
Findings Value (n, %)
Oral dysphagia   40 (18.1)
Inadequate labial closure   1 (0.5)
Inadequate tongue movement   25 (11.3)
Pharyngeal dysphagia 154 (69.7)
Delayed swallowing refl  ex   95 (43.0)
Inadequate closure of velopharyngeal port 15 (6.8)
Inadequate pharyngeal peristalsis   97 (43.9)
Reduced laryngeal elevation   45 (20.4)
Vallecular remnant  119 (53.8)
Cricopharyngeal dysfunction   27 (12.2)
Aspiration
None 110 (49.8)
Present 111 (50.2)Soo Jin Jung, et al.
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the highest proportion of patients with pharyngeal 
phase dysphagia (119, 53.8%), followed by inadequate 
pharyngeal peristalsis (97, 43.9%), delayed swallowing 
reflex (95, 43.0%), and reduced laryngeal elevation (45, 
20.4%) (Table 2).
Risk factors associated with aspiration in HNC
  Aspiration occurred at a signifi  cantly higher incidence 
in patients aged ≥65 years than in patients aged <65 
years (p<0.05). However, no inter-gender diff  erence was 
observed. Aspiration showed a higher incidence during 
the period from onset to examination (p<0.05).
  Aspiration occurred at a signifi  cantly higher incidence 
Table 3. Incidence of Aspiration and the Univariate and Multivariate Analyses of Patient Factors
Variable
Composite 
aspiration (n, %)
p
Multivariate OR 
(95% CI)
p
Gender 0.180
Male 91 (52.6)
Female 20 (41.6)
Age (y) 0.001* 0.005*
<65 60 (42.2)  1 (referent) 
≥65 51 (64.5) 2.499 (1.319-4.736)
Duration from onset to examination
 (months)
<3 32 (29.6) 0.000*
3-6 12 (52.1)
6-12 22 (66.6) 
≥12 45 (78.9)
Primary site 0.248
OPx, OC, SG 86 (48.3)
Lx, HPx, NPx 25 (58.1)
T stage 0.003*
T1-T2 64 (43.2)
T3-T4 47 (64.4)
N stage 0.022*
N0 32 (40.0)
N1-2 79 (56.0)
AJCC stage 0.000*  0.007*
Stage I-II 33 (33.7)  1 (referent)
Stage III-IV 78 (61.9) 2.350 (1.258-4.390)
Operation 0.000* 0.002*
No 41 (36.9)  1 (referent)
Yes 70 (63.6) 2.617 (1.441-4.752)
Chemotherapy 0.000* 0.002*
No  76 (42.2) 1 (referent)
Yes 35 (85.4) 4.743 (1.802-12.487)
Radiotherapy 0.000*
No 79 (43.2)
Yes 32 (84.2)
Lx: Larynx, HPx: Hypopharynx, OPx: Oropharynx, OC:Oral cavity, NPx: Nasopharynx, SG: Salivary gland
*p<0.05Rick Factors of Aspiration in Head and Neck Cancer
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in tumors classified as T3 or T4 than in those classified 
as T1 or T2 (p<0.05). Additionally, the incidence was 
significantly higher in tumors extending into the lymph 
nodes (p<0.05). Aspiration incidence was higher in 
patients classified as AJCC stage III or IV than in those 
classifi  ed as stages I or II (p<0.05). Tumors were located 
slightly more frequently in the larynx or pharynx than 
in the oral cavity, but the diff  erence was not signifi  cant. 
Aspiration showed a statistically significant higher inci-
dence in patients who underwent an operation, chemo-
therapy, or radiotherapy than in those who did not start 
treatment (p<0.05).
  Multivariate logistic regression analyses revealed that 
patients aged ≥65 years, who were classifi  ed as AJCC stage 
III or IV, who underwent operation, and who underwent 
chemotherapy were the high-risk group (p<0.05). The 
incidence of aspiration was 2.5 times higher in patients 
aged ≥65 years than in those aged <65 years (odds ratio 
[OR], 2.499 (95% confidence interval [CI], 1.319-4.736) 
and was 2.4 times higher in patients classified as AJCC 
stage III or IV than in those classifi  ed as stage I or II (OR, 
2.350; 95% CI, 1.258-4.390). The incidence of aspiration 
was 2.6 times higher in patients who underwent an 
operation than in those who did not (OR, 2.6; 95% CI, 
1.4-4.8). In particular, the incidence of aspiration was 4.7 
times higher in patients who underwent chemotherapy 
than in those who did not (OR, 2.617; 95% CI,1.441-4.752) 
(Table 3).
Table 4. Incidence of Aspiration and the Univariate and Multivariate Analyses of Videofl  uroscopic Swallowing Study 
Findings
Variable
Composite aspiration 
(n, %)
p
Multivariate OR 
(95% CI)
p
Labial closure 0.318 
Intact 110 (50.0)
Inadequate 1 (100.0)
Tongue movement 0.000*
Intact 88 (44.9)
Inadequate 23 (92.0)
Swallowing refl  ex 0.000* 0.000*
Normal 30 (23.8)  1 (referent)
Delayed 81 (85.2) 14.462 (7.036-29.726)
Closure of velopharyngeal port 0.000*
Intact 99 (48.0)
Inadequate 12 (80.0)
Pharyngeal peristalsis 0.000*
Intact 37 (78.2)
Inadequate 74 (76.2)
Elevation of larynx 0.000* 0.031*
Normal  73 (41.4)  1 (referent)
Reduced 38 (84.4) 3.038 (1.110-8.317)
Cricopharyngeal dysfunction 0.025*
No 92 (47.4)
Yes 19 (70.3)
Vallecular remnant 0.000*
None 28 (27.4)
Present 83 (69.7)
*p<0.05Soo Jin Jung, et al.
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Abnormal swallowing ﬁ  ndings associated with aspira-
tion on VFSS
  Inadequate tongue movement was related to aspiration 
during the oral phase. At the pharyngeal phase, factors 
associated with aspiration were decreased pharyngeal 
reflex, inadequate closure of the velopharyngeal port, 
in  ade  quate pharyngeal peristalsis, reduced laryngeal 
elevation, cricopharyngeal dysfunction, and the presence 
of a vallecular remnant (p<0.05). The multivariate logi-
stic regression analysis revealed that the incidence of 
aspiration was 14.5 times higher in patients with a de-
creased pharyngeal refl  ex than that in patients without a 
decreased pharyngeal refl  ex (OR, 14.5; 95% CI, 7.0-29.7) 
and was 3.0 times higher in those with reduced laryngeal 
elevation than in those without (OR, 3.038; 95% CI, 1.110-
8.317) (p<0.05) (Table 4).
DISCUSSION
  Aspiration occurred in 50.2% of patients with HNC, 
which agreed with that of previous studies (36-94%).
1-6
  Aspiration in patients with HNC may be caused by 
various factors, including abnormal motility of swal-
lowing-related structures,
21 resection of a tumor, struc-
tural muscular, bony, or cartilage damage caused by 
surgery or by scar tissue formation from radiotherapy, 
or by the abnormal motility of the oral, pharyngeal, and 
laryngeal muscles caused by cell apoptosis resulting from 
chemotherapy.
22,23 In this study, VFSS was performed 
on comparatively more patients with HNC (221) than 
those used in previous studies, which made it possible to 
analyze the characteristics of patients and HNC as well as 
to identify major risk factors for aspiration.
  Gender was not related to aspiration, but age was sig-
ni  ficantly related to aspiration incidence. Previous stu-
dies showed different results regarding the correlation 
between age and aspiration. Caudell et al.
19 reported 
that advanced age was an important factor predicting 
dysphagia in patients with HNC who underwent treat-
ment. Advanced age was related to the incidence of 
aspiration in a study conducted on healthy subjects.
23,24 
Th   e correlation between age and aspiration has not been 
clarified yet. However, the incidence of aspiration may 
increase not only with natural aging but by comorbidities 
that can aff  ect the swallowing function.
  Aspiration showed a signifi  cantly higher incidence from 
onset to examination. But significant differences were 
not observed when other variables were controlled in 
the multivariate logistic regression analysis. According 
to the report of Logemann et al.
25 who performed VFSS 
on patients 3 and 12 months after they underwent radio-
therapy or chemoradiotherapy, dysphagia and aspiration 
showed significantly higher incidences before and 3 
months after treatments. But, significant changes were 
not observed 12 months after treatments. In a study by 
Petterson et al.,
20 the functional endoscopic swallowing 
study and the 100 cc water swallowing test were per-
for  med on patients who underwent radiotherapy or 
chemoradiotherapy. The incidence of aspiration in-
creased at 3, 6, and 12 months after the operations, 
respectively, rather than before the operations. However, 
no inter-period diff  erences were reported. In this study, 
the incidence of aspiration increased in proportion to the 
duration from onset to examination. Th   e incidence may 
not have been aff  ected by duration itself but by increasing 
the proportion of patients who underwent operations, 
chemotherapy, or radiotherapy with time. These results 
were similar to those of previous studies.
  Interestingly, tumor location was not a risk factor in 
this study. In contrast, Stenson et al.
13 reported that the 
incidence rate of aspiration reaches 30, 67, and 80% 
in patients with oral, laryngeal, and pharyngeal HNCs 
respectively, whereas Starmer et al.
18 reported that 
HNC extending into the larynx or the hypopharynx is 
a principal risk factor for aspiration. Campbell et al.
26 
reported that tumor location has no relation to aspi  ra-
tion in subjects who survived for 5 years or longer after 
undergoing treatment. Eischbruch et al.
6 reported that 
though swallowing-related structures were normal, 
radio  therapy and chemotherapy affects movement of 
the oral cavity and laryngopharyngeal musculature and, 
thus, causes aspiration. Chapuy et al.
27 reported that 
tumor location does not aff  ect the risk of gastrostomy in 
patients who underwent radiotherapy, chemotherapy, 
or an operation. Taken together, aspiration in patients 
with HNC is affected by their history of radiotherapy, 
chemotherapy, or an operation rather than by tumor 
location.
  In this study, tumor size, lymph node stage and AJCC 
stage were associated with aspiration, and AJCC stage 
was the principal predictive factor. Stenson et al.
13 re-
ported that AJCC stage has no relationship to the in-Rick Factors of Aspiration in Head and Neck Cancer
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cidence of aspiration in patients with HNC. In contrast, 
Nguyen et al.,
28 who conducted a study on patients with 
oropharyngeal cancer that underwent radiotherapy or 
chemotherapy, reported that the risk of aspiration was 
higher in patients with tumors classifi  ed as T3 or T4 than 
in those classifi  ed as T1 or T2. Th   is result was consistent 
with the report of Chapuy et al.
27 who found that tumor 
locations do not heighten the risk for gastrotomy in 
patients who undergo radiotherapy, chemotherapy, or an 
operation, suggesting that higher AJCC stage is relevant 
to the occurrence of aspiration and, at the same time, 
needs more aggressive therapies.
  The incidence of aspiration was significantly higher in 
patients with HNC who underwent an operation than 
in those who did not, and operation history was an 
independent predictive factor. Previous studies have 
indicated that the incidence rate of aspiration is 10-
37%
29 and 50-67%
30 in patients who undergo a total 
glossectomy and supraglottic laryngectomy, respectively. 
Such operations remove not only tumors but normal 
muscles and bones for the purpose of marginal security, 
and, as a result, swallowing-related organs malfunction. 
Despite that the flap operation was performed, it re-
sulted in restricted motion. Dysphagia may occur after 
sur gery.
31 According to the report by Lango et al.,
32 tissue 
fibrosis and edema were aggravated in patients who 
underwent an operation in addition to radiotherapy 
or chemotherapy, which remarkably heightens the 
pos  sibility of tube feeding. Thus, surgery may be an 
additional risk factor for aspiration.
  Chemotherapy is a principal predictive factor of aspi-
ration. Nguyen et al.
33 reported that the incidence rate of 
aspiration increases from 17% to 59% after chemotherapy. 
Odynophagia caused by mucositis, glossitis, fibrosis, 
and lymphedema resulting from apoptosis caused by 
cytotoxic anticancer drugs aff  ects aspiration.
34
  Radiotherapy is related with aspiration. Pauloski and 
Logemann
35 reported that radiotherapy heightens the risk 
of aspiration by 35% and increases vallecular remnants. 
This occurs because radiotherapy causes fibrosis and 
decreases muscle activity of swallowing-related struc-
tures.
5,34 However, we found that radiotherapy was rele-
vant to aspiration but was not a principal predictive 
factor. In contrast, chemotherapy was a principal risk 
factor. These results agree with the report of Nguyen et 
al.
33 that dysphagia develops more often in patients who 
undergo both chemotherapy and radiotherapy than in 
those who undergo radiotherapy alone. Caudell et al.
19 
reported that chemotherapy is the most important risk 
factor causing severe dysphagia in patients who undergo 
radiotherapy. It is necessary to compare radiotherapy 
and chemotherapy separately with a sufficient number 
of patients. Actually, there are few cases in which che-
motherapy or radiotherapy is independently performed. 
Similarly, in this study, only a few patients underwent 
radiotherapy or chemotherapy alone.
  Eisbruch et al.
6 reported reduced base-of-tongue re  trac-
tion (41%), delayed swallowing refl  ex (36%), the presence 
of a vallecular remnant (23%), and reduced pharyngeal 
and laryngeal elevation (18%) in patients with HNC 
before therapy. After chemoradiotherapy, reduced 
base-of-tongue retraction (85%), delayed swallowing 
reflex (62%), presence of a vallecular remnant (77%), 
and reduced pharyngeal and laryngeal elevation (46%) 
showed a higher prevalence. In addition, velopharyngeal 
port dysfunction (15%) and incomplete cricopharyngeal 
relaxation (46%) were newly observed after treatments. 
Wu et al.
36 reported that oropharyngeal dysfunc  tion 
(75%), delayed swallowing reflex (87.1%), presence of a 
vallecular remnant (93.5%), and incomplete pharyngeal 
contraction (82.8%) occurred at higher frequencies in 
patients with nasopharyngeal cancer who underwent 
radiotherapy, and that they had a relationship to aspira-
tion. Galli et al.
37 reported that pharyngeal residue 
occurred more frequently in patients who underwent 
an operation than in those with neurological dysphagia. 
Th   is study showed similar results, and inadequate tongue 
movement, delayed swallowing refl  ex, inadequate closure 
of the velopharyngeal port, inadequate pharyngeal peri-
stalsis, reduced laryngeal elevation, cricopharyngeal 
dysfunction, and presence of a vallecular remnant were 
related with aspiration. In particular, delayed swallowing 
refl  ex and reduced laryngeal elevation were principal risk 
factors, which was not consistent with the report of Wu 
et al.
8 who found that inadequate pharyngeal peristalsis 
and cricopharyngeal dysfunction are related to aspiration 
in patients with nasopharyngeal cancer who underwent 
radiotherapy. The reason might be that endoscopy 
cannot evaluate laryngeal elevation. Reduced laryngeal 
elevation was related to the occurrence of aspiration in 
the study by Logemann and Bytell.
38
  The limitation of this study was that the results were Soo Jin Jung, et al.
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based on a retrospective analyses of medical records, 
not bedside or clinical demonstrations. Th  us,  infl  uential 
factors may not have been controlled. Th   is study was not 
conducted on all the patients with HNC in this hospital 
but on patients referred from other departments to the 
department of rehabilitation medicine for VFSS, which 
may have caused some biases. Moreover, the statistical 
analysis was not as accurate due to the small number of 
patients who underwent chemotherapy or radiotherapy 
alone. Additional limitations may have occurred due to 
treatment modalities that varied depending on tumor 
stage. Accordingly, a large-scale prospective study should 
be conducted on patients with HNC.
CONCLUSION
  Advanced age, higher tumor stage, and a history of 
an operation and chemotherapy were principal risk 
factors for aspiration in patients with HNC. Th  us,  precise 
examinations, including VFSS, should be performed 
on patients with HNC. The VFSS results showed that 
the delayed swallowing reflex and reduced laryngeal 
elevation might be risk factors for aspiration, which 
suggests that dysphagia rehabilitation should be con-
ducted based on such characteristics.
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